Bobak Azamian was Appointed as Chief Executive Officer at Tarsus-Pharmaceuticals

Date of management change: January 14, 2017 

What Happened?

Irvine, CA-based Tarsus-Pharmaceuticals Appointed Bobak Azamian as Chief Executive Officer

 

About the Company

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.

 

About the Person

Bobak Azamian is Chief Executive Officer at Tarsus Pharmaceuticals. Previously, Bobak held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Falconer Beth, Lian Pat, D'Angina Joseph, bougas debbie, Hanna Bill, Chestnut Aaron, Kuhns Mark, Fernandez Andre, Sibley Annette, Slavensky Elizabeth, Meyers Carl

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.